Skip to content

Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure

Neurocognitive impairment results in poorer adherence to HIV therapy

Small UK study suggests that depression does not have an impact on hepatitis C treatment outcomes in people co-infected with HIV

US research shows that HPV vaccination could prevent pre-cancerous anal cell changes in HIV-positive gay men

Support improves hepatitis C treatment completion and response rates among drug users

Smoking has a bigger impact on the prognosis of HIV-positive patients than HIV-related factors

Aggressive therapy for MDR-TB reduces risk of disease recurrence

Poor CD4 response to HIV treatment increases risk of death from non-AIDS-related illnesses, even for those with higher baseline counts

Child death rates still high despite HIV treatment